Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biomater Adv ; 159: 213802, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38401401

RESUMEN

The rapid metastasis & heterogenic constitution of triple negative breast cancer (TNBC) limits drug entry to the tumor, reducing treatment effectiveness. To address this, we have synthesized Casein nanoparticles (Cn NPs) with attached glutathione (GSH), a natural ligand for cancer cell overexpressed γ-glutamyl transpeptidase (GGT). Cn NPs encapsulated with Camptothecin and NIR dye IR 797 (CCN NPs) for combinatorial therapy of TNBC. The GSH-CCN nanoparticles (CCNG NPs) act as a Nano-Trojan to deceive the cancer cells by delivering therapeutic payloads directly to specific target cells. In this study, Casein Nano-Trojan is equipped with GSH as a targeting ligand for GGT. The binding of CCNG NPs with cell surface receptors switched the anionic charge to catanionic, prompting the target cell to engulf the nanoparticles. The Casein Nano-Trojan releases its therapeutic payload inside the target cell, potentially inhibiting proliferation & inducing a high percentage of cell death (85 ± 7 %). Disintegration of mitochondrial membrane potential, inhibition of both migration & re-growth were observed. Immunofluorescence, acridine orange/ethidium bromide stain, and nuclear fragmentation assay further confirmed the substantial DNA damage induced by the high expression of γH2AX and p53. Significant therapeutic efficacy was observed in the 3D spheroids of 4T1 cells and in vivo breast cancer mice model (BALB/c). These findings demonstrate that CCNG NPs could be an effective treatment approach for highly metastatic triple negative breast cancer.


Asunto(s)
Camptotecina , Neoplasias de la Mama Triple Negativas , Humanos , Animales , Ratones , Camptotecina/farmacología , Camptotecina/uso terapéutico , Neoplasias de la Mama Triple Negativas/tratamiento farmacológico , Neoplasias de la Mama Triple Negativas/metabolismo , Neoplasias de la Mama Triple Negativas/patología , Caseínas/uso terapéutico , Ligandos , Línea Celular Tumoral , Glutatión
2.
Sci Rep ; 13(1): 6371, 2023 04 19.
Artículo en Inglés | MEDLINE | ID: mdl-37076562

RESUMEN

In this research work, carbon dots (CDs) were synthesized from the renewable leaves of an indigenous medicinal plant by the one-pot sand bath method, Azadirachta indica. The synthesized CDs were characterized for its optical properties using UV-Vis, Fluorescence and Fourier transform infrared (FT-IR) spectrophotometry and for structural properties using dynamic light scattering (DLS), X-ray Diffraction (XRD) and high resolution Transmission electron microscopy (HR-TEM). The synthesized CDs exhibited concentration dependent biocompatibility when tested in mouse fibroblast L929 cell line. The EC50 values of biomedical studies, free radical scavenging activity (13.87 µgmL-1), and total antioxidant capacity (38 µgmL-1) proved CDs were exceptionally good. These CDs showed an appreciable zone of inhibition when examined on four bacterial (two gram-positive and gram-negative) and two fungal strains at minimum concentrations. Cellular internalisation studies performed on human breast cancer cells (MCF 7- bioimaging) revealed the applicability of CDs in bioimaging, wherein the inherent fluorescence of CDs were utilised. Thus, the CDs developed are potential as bioimaging, antioxidants and antimicrobial agents.


Asunto(s)
Antiinfecciosos , Plantas Medicinales , Puntos Cuánticos , Animales , Ratones , Humanos , Antioxidantes/farmacología , Antioxidantes/análisis , Espectroscopía Infrarroja por Transformada de Fourier , Carbono/química , Puntos Cuánticos/química , Antiinfecciosos/farmacología , Antiinfecciosos/análisis , Hojas de la Planta/química
3.
Pharmaceutics ; 15(2)2023 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-36839797

RESUMEN

Treatment of retinoblastoma is limited due to its delayed detection and inaccesbility of drugs to reach the retina crossing the blood-retinal barrier. With the advancements in nanotechnology, photothermal therapy (PTT) employing plasmonic nanomaterials and/or NIR dyes have emerged as an affordable alternative owing to the spatial control that is offered by the modality leading to localized and enhanced therapeutic efficacy with minimal invasiveness. However, the modality is limited in its clinical application owing to the increased heat shock resistance of the tumor cells in response to the heat that is generated via PTT. Hence, in this study, we explore the role of novel biomolecular fraction of Moringa oleifera (DFM) encapsulated within a polymeric nanosystem, for its anti-heat shock protein (HSP) activity. The MO extract was co-encapsulated with NIR sensitizing dye, IR820 into a biodegradable polycaprolactone (PCL) nano-delivery system (PMIR NPs). The photothermal transduction efficacy of PMIR NPs was validated in vitro against retinoblastoma cell lines. The inherent fluorescence of DFM was utilized to evaluate the cellular internalization of the PMIR NPs using fluorescence microscopy and flow cytometry. The overall oxidative protein damage and downregulation of HSP70 expression upon treatment with PMIR NPs and NIR laser irradiation was evaluated using densiometric protein analysis and Western blotting. Overall, the PMIR NPs exhibited excellent anti-cancer activity when combined with PTT with downregulated HSP70 expression against retinoblastoma cells.

4.
ACS Macro Lett ; 12(2): 255-262, 2023 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-36723076

RESUMEN

With the advent of nucleosome/nucleotide intercalating drugs, DNA-based nanocarriers have recently gained impetus. However, most of the newly proposed DNA nanosystems are rather complex, thereby having low scalability and translatability. In this study, we propose a simple DNA nanomatrix core encapsulated within a chitosan shell, which is expected to enhance the encapsulation efficiency of intercalating drugs. This has been demonstrated using proflavine hemisulfate (PfHS), a model intercalating agent that shows improved ROS generation, among other anticancerous properties. The release of the drug from the nanomatrix is triggered by providing a heat trigger using IR-792 perchlorate, a known NIR photothermal sensitizer.


Asunto(s)
Doxorrubicina , Terapia Fototérmica , Sistemas de Liberación de Medicamentos , Tecnología , ADN
5.
ACS Appl Bio Mater ; 6(2): 349-364, 2023 02 20.
Artículo en Inglés | MEDLINE | ID: mdl-36700563

RESUMEN

Conventional cancer treatment modalities are often associated with major therapeutic limitations and severe side effects. Photodynamic therapy is a localized noninvasive mode of treatment that has given a different direction to cancer research due to its effectivity against a wide range of cancers and minimal side effects. A photosensitizer is the key component of photodynamic therapy (PDT) that generates cytotoxic reactive oxygen species to eradicate cancer cells. As the therapeutic effectivity of PDT greatly depends upon the photosensitizer, great efforts have been made to search for an ideal photosensitizer. Chlorin e6 is a FDA approved second generation photosensitizer that meets the desired clinical properties for PDT. It is known for its high reactive oxygen species (ROS) generation ability and anticancer potency against many types of cancer. Hydrophobicity is a major drawback of Ce6 that leads to its poor biodistribution and rapid clearance from the circulatory system. To overcome this drawback, researchers have designed and fabricated several types of nanosystems, which can enhance Ce6 solubility and thereby enhance its bioavailability. These nanosystems also improve tumor accumulation of Ce6 by selectively targeting the cancer cells through passive and active targeting. In addition, Ce6 has been employed in many combination therapies like chemo-photodynamic therapy, photoimmunotherapy, and combined photodynamic-photothermal therapy. A combination therapy is more curative than a single therapy due to the synergistic effects of individual therapies. Ce6-based nanosystems for combination therapies have shown excellent results in various studies and provide a promising platform for cancer treatment.


Asunto(s)
Neoplasias , Fotoquimioterapia , Fármacos Fotosensibilizantes/farmacología , Fotoquimioterapia/métodos , Línea Celular Tumoral , Nanomedicina , Especies Reactivas de Oxígeno , Distribución Tisular , Neoplasias/tratamiento farmacológico
6.
Spectrochim Acta A Mol Biomol Spectrosc ; 252: 119545, 2021 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-33588365

RESUMEN

Flavonoids have various medicinal properties such as anti-inflammatory, anti-oxidant, anti-cancer, antiviral. Yet, the fluorescent properties of flavonoids are less explored and termed as autofluorescence in general. This study investigates the fluorescence properties of Isoliquiritigenin (ISL) in various alkaline conditions. The maximum fluorescence emission was obtained at pH 12 on excitation wavelength of 440 nm. Theoretical and experimental investigation on the shift in UV-Vis absorbance spectra, upon the variation in pH, performed, indicated deprotonation as the cause. PEG-based stable liposome carrier, with an internal alkaline environment (LIP-ISL-NaOH) that aids in flavonoid fluorescence, was synthesized using a modified thin-film hydration method. The hydrodynamic size of the liposome synthesized was in the range of 50-70 nm. PEG, on the addition, found maintaining the alkaline environment in the internal chamber of the lipo-polymer system, helps the LIP-ISLNaOH nanosystem to exhibit fluorescence irrespective of the suspension pH. Further, reducing property of ISL was used for the synthesis of Au nanoclusters to achieve theranostic nature.


Asunto(s)
Chalconas , Fluorescencia , Concentración de Iones de Hidrógeno , Polímeros
7.
Cancer Treat Res Commun ; 26: 100303, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33454575

RESUMEN

Cancer metastasis remains the major cause of global cancer deaths. Radiation therapy remains one of the golden standards for cancer treatment. Nanomedicine based strategies have been designed and developed in order to improve the clinical outcomes of cancer therapy and diagnosis at molecular levels. Over the years, several researchers have shown their interest in using radiosensitizers made of high Z elements. Metal-based nanosystems also play a dual role by enhancing the synergistic effect of cell killing via various biological immune responses. This review summarizes the role of Nano-sensitizers in boosting radiation (ionizing/non-ionizing radiations) induced biological responses in treatment of metastatic cancer models.


Asunto(s)
Antineoplásicos Inmunológicos/administración & dosificación , Quimioradioterapia/métodos , Nanopartículas/administración & dosificación , Neoplasias/terapia , Fármacos Sensibilizantes a Radiaciones/administración & dosificación , Animales , Modelos Animales de Enfermedad , Humanos , Neoplasias/inmunología , Neoplasias/mortalidad , Tolerancia a Radiación/efectos de los fármacos , Análisis de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...